Archive for the ‘Asset Management’ Category

Investment – Daily Recommendations

 

Symbol

Company

Sector

Horizon

Upside Target

Risk Profile

Rating

CYTX.US

Cytori Therapeutics

Biotechnology

Very-Short-Term

586.34%

 0.85

 1.17

ADXS.US

Advaxis

Biotechnology

Very-Short-Term

188.16%

 0.88

 1.17

RNN.US

Rexahn Pharmaceuticals

Biotechnology

Very-Short-Term

1571.34%

 0.74

 1.11

VTVT.US

Vtv Therapeutics

Pharmaceuticals

Very-Short-Term

219.97%

 0.79

 1.12

OCUL.US

Ocular Therapeutix

Pharmaceuticals

Very-Short-Term

245.42%

 0.70

 1.11

STML.US

Stemline Therapeutics

Biotechnology

Very-Short-Term

211.52%

 0.77

 1.42

GNCA.US

Genocea Biosciences

Biotechnology

Very-Short-Term

216.72%

 0.81

 1.56

CATB.US

Catabasis Pharmaceuticals

Biotechnology

Very-Short-Term

337.22%

 0.65

 1.85

AVXL.US

Anavex Life Sciences

Pharmaceuticals

Very-Short-Term

161.22%

 0.76

 1.08

PHARM.NL

Pharming Group

Biotechnology

Very-Short-Term

196.66%

 0.80

 1.00

PBMD.US

Prima Biomed

Biotechnology

Very-Short-Term

171.33%

 0.77

 1.12

ADMS.US

Adamas Pharmaceuticals

Pharmaceuticals

Short-Term

89.54%

 0.81

 1.23

RIGL.US

Rigel Pharmaceuticals

Pharmaceuticals

Very-Short-Term

123.89%

 0.71

 1.24

PLI.CA

Prometic Life Sciences

Biotechnology

Very-Short-Term

134.97%

 0.90

 1.37

ADAP.US

Adaptimmune Therapeutics

Biotechnology

Very-Short-Term

171.33%

 0.73

 1.77

AUPH.US

Aurinia Pharmaceuticals

Pharmaceuticals

Short-Term

53.10%

 0.84

 1.09

ABUS.US

Arbutus Biopharma

Biotechnology

Short-Term

119.32%

 0.80

 1.62

VBLT.US

Vascular Biogenics

Biotechnology

Very-Short-Term

65.36%

 0.72

 1.15